Forte Biosciences, Inc. (FBRX) Change in Acquisitions & Divestments (2016 - 2020)
Forte Biosciences (FBRX) has disclosed Change in Acquisitions & Divestments for 5 consecutive years, with $12.7 million as the latest value for Q1 2020.
- On a quarterly basis, Change in Acquisitions & Divestments fell 54.3% to $12.7 million in Q1 2020 year-over-year; TTM through Mar 2020 was $78.4 million, a 10.21% decrease, with the full-year FY2023 number at $10.1 million, changed N/A from a year prior.
- Change in Acquisitions & Divestments was $12.7 million for Q1 2020 at Forte Biosciences, down from $16.8 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $27.8 million in Q1 2019 to a low of $8.3 million in Q1 2016.
- A 5-year average of $15.7 million and a median of $13.6 million in 2017 define the central range for Change in Acquisitions & Divestments.
- Peak YoY movement for Change in Acquisitions & Divestments: soared 206.33% in 2019, then crashed 54.3% in 2020.
- Forte Biosciences' Change in Acquisitions & Divestments stood at $11.4 million in 2016, then decreased by 3.13% to $11.1 million in 2017, then skyrocketed by 74.63% to $19.3 million in 2018, then decreased by 12.94% to $16.8 million in 2019, then decreased by 24.43% to $12.7 million in 2020.
- Per Business Quant, the three most recent readings for FBRX's Change in Acquisitions & Divestments are $12.7 million (Q1 2020), $16.8 million (Q4 2019), and $27.7 million (Q3 2019).